|
⚲
|
| Keyboard |
| Lundquist David J
✚
|
|
|---|---|
| CIK # | 0001512133 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 4 | [0001512133] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Lundquist David J | |
| Lumos Pharma Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Lumos Pharma Inc [NLNK]
Common Stock
|
2012-03-05 | Option exercise | 26,190 | $3.07 | 80,403 |
|
Lumos Pharma Inc [NLNK]
Stock Option (Right to Buy) · derivative
|
2012-03-05 | Option exercise | 26,190 | $0.00 | |
|
Lumos Pharma Inc [NLNK]
Common Stock
|
2012-03-01 | Option exercise | 11,904 | $2.10 | 24,998 |
|
Lumos Pharma Inc [NLNK]
Common Stock
|
2012-03-01 | Option exercise | 7,142 | $2.10 | 14,998 |
|
Lumos Pharma Inc [NLNK]
Stock Option (Right to Buy) · derivative
|
2012-03-01 | Option exercise | 11,904 | $0.00 | |
|
Lumos Pharma Inc [NLNK]
Stock Option (Right to Buy) · derivative
|
2012-03-01 | Option exercise | 7,142 | $0.00 |